Suppr超能文献

全球研究中的生物伦理学论坛会议,“在低收入和中等收入国家研究中的替代临床试验设计和方法的伦理学”:新兴主题和成果。

The global forum on bioethics in research meeting, "ethics of alternative clinical trial designs and methods in low- and middle-income country research": emerging themes and outputs.

机构信息

Wellcome Trust, 215 Euston Road, London, NW1 2BE, UK.

Pan American Health Organisation, Washington, DC, USA.

出版信息

Trials. 2019 Dec 19;20(Suppl 2):701. doi: 10.1186/s13063-019-3840-3.

Abstract

Alternative clinical trial designs and methods are increasingly being used in place of the conventional individually randomised controlled trial (RCT) in high-income and in low-income and middle-income country (LMIC) research. These approaches - including adaptive, cluster-randomised and stepped-wedge designs and controlled human infection models - offer a number of potential advantages, including being more efficient and making the clinical trial process more socially acceptable. However, these designs and methods are generally not familiar to researchers, research ethics committees and regulators and their ethical implications have not received sufficient international attention from the bioethics, research, and policymaking communities working together. The ethics of alternative clinical trial designs and methods in LMIC research was chosen as a topic for the 2017 Global Forum on Bioethics in Research (GFBR). The meeting opened a global dialogue about this emerging issue in research ethics and gave voice to the LMIC perspective. It identified the need to take a multidisciplinary approach and to develop capacity amongst researchers and research ethics committees and regulators to propose, review and regulate these novel designs and methods. Building skills and infrastructure will empower researchers to choose from a broad range of designs and methods and adopt the most scientifically suitable, efficient, ethical and context-appropriate of these. The need for capacity development is most pressing from the LMIC perspective, where limited resources create an urgency to seek the most efficient trial design and method. The aim of this paper is to encourage broad debate about this complex area of research. By opening up this debate, GFBR aims to promote the appropriate and ethical use of novel designs and methods so their full potential to address the health needs in LMICs can be realised.

摘要

替代临床试验设计和方法越来越多地被用于替代传统的个体随机对照试验(RCT),无论是在高收入国家还是低收入和中等收入国家(LMIC)的研究中。这些方法——包括适应性、整群随机和阶梯式楔形设计以及受控人体感染模型——具有许多潜在优势,包括更高效和使临床试验过程更被社会接受。然而,这些设计和方法通常不为研究人员、研究伦理委员会和监管机构所熟悉,其伦理含义也没有得到共同努力的生物伦理学、研究和决策制定界的充分关注。替代临床试验设计和方法在 LMIC 研究中的伦理问题被选为 2017 年全球研究伦理生物伦理学论坛(GFBR)的一个议题。会议就这一研究伦理新兴问题展开了全球对话,并为 LMIC 的观点发声。它确定了需要采取多学科方法,并在研究人员、研究伦理委员会和监管机构中培养能力,以提出、审查和监管这些新的设计和方法。培养技能和基础设施将使研究人员能够从广泛的设计和方法中进行选择,并采用最科学、高效、合乎伦理和适合背景的设计和方法。从 LMIC 的角度来看,能力建设的需求最为紧迫,因为有限的资源使得寻求最有效的试验设计和方法变得紧迫。本文的目的是鼓励对这一复杂研究领域进行广泛的辩论。通过展开这场辩论,GFBR 旨在促进新颖设计和方法的恰当和合乎伦理的使用,从而充分发挥它们在解决 LMIC 健康需求方面的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09dd/6921436/d804702f1154/13063_2019_3840_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验